Edition:
India

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

48.81EUR
17 May 2019
Change (% chg)

€-0.20 (-0.41%)
Prev Close
€49.01
Open
€48.69
Day's High
€48.88
Day's Low
€47.74
Volume
2,148,516
Avg. Vol
1,729,897
52-wk High
€71.36
52-wk Low
€38.28

Select another date:

Fri, May 17 2019

Photo

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

Fresenius CEO: Don't see us making any large acquisitions this year

BERLIN, May 17 German healthcare group Fresenius probably will not make any large acquisitions this year, the group's chief executive officer said on Friday, adding that this was more likely from next year.

Fresenius talking to potential suitors about sale of blood transfusion business - sources

FRANKFURT Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.

UPDATE 1-Fresenius talking to potential suitors about sale of blood transfusion business - sources

* Fresenius has hired Goldman Sachs for potential sale - sources

Fresenius talking to potential suitors about sale of blood transfusion business - sources

FRANKFURT, May 10 Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.

UPDATE 2-Fresenius makes solid start to year after turbulent 2018

* Confirms full-year guidance (Adds analysts, shares, details)

Fresenius makes solid start to Q1 after troubled 2018

BERLIN, May 2 Fresenius reported a quarter of solid sales and earnings growth on Thursday helped by its generic infusion drugs and dialysis units and signs of stabilisation at its troubled German hospital business.

Fresenius may not be ideal owner for some business activities: CEO

DUESSELDORF, Germany German healthcare group Fresenius is happy with its current portfolio but may consider selling some non-core business activities within its units, its chief executive told an association of business journalists on Wednesday evening.

Fresenius may not be ideal owner for some business activities -CEO

DUESSELDORF, Germany, April 11 German healthcare group Fresenius is happy with its current portfolio but may consider selling some non-core business activities within its units, its chief executive told an association of business journalists on Wednesday evening.

UPDATE 2-Fresenius flags faster earnings growth from 2020 after investment

* Announces 1 bln euros share buyback at Fresenius Medical Care

Select another date: